Skip to content

Palliative chemotherapy in advanced esophageal cancer

Prognostic and predictive factors for use of palliative chemotherapy in advanced stage esophageal/ gastroesophageal junction cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2014/03/004496
Enrollment
200
Registered
2014-03-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Palliative Therapy for Cancer

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Retrospective analysis of prospectively collected data from September 2010- to â??to dateâ??. Patients of locally advanced, metastatic, relapsed/ recurrent Oesophageal/gastroesophageal junction cancers eligible for palliative chemotherapy and who received treatment in Tata Memorial hospital or were given treatment plan or referral letter for their local place will be included in the study.

Exclusion criteria

Exclusion criteria: Not Applicable

Design outcomes

Primary

MeasureTime frame
To determine the clinical and laboratory factors predicting for response and affecting overall survival in patients receiving palliative chemotherapy for advanced oesophageal/ gastroesophageal cancer.Timepoint: 1 year

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactDr Assem Samar

Tata Memorial Hospital

aseemtmh@gmail.com9004399604

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026